...
首页> 外文期刊>Angewandte Chemie >Smart Design of Nanomaterials for Mitochondria-Targeted Nanotherapeutics
【24h】

Smart Design of Nanomaterials for Mitochondria-Targeted Nanotherapeutics

机译:线粒体靶向纳米治疗型纳米材料的智能设计

获取原文
获取原文并翻译 | 示例
           

摘要

Mitochondria are the powerhouse of cells. They are vital organelles that maintain cellular function and metabolism. Dysfunction of mitochondria results in various diseases with a great diversity of clinical appearances. In the past, strategies have been developed for fabricating subcellular-targeting drug-delivery nanocarriers, enabling cellular internalization and subsequent organelle localization. Of late, innovative strategies have emerged for the smart design of multifunctional nanocarriers. Hierarchical targeting enables nanocarriers to evade and overcome various barriers encountered upon in vivo administration to reach the organelle with good bioavailability. Stimuli-responsive nanocarriers allow controlled release of therapeutics to occur at the desired target site. Synergistic therapy can be achieved using a combination of approaches such as chemotherapy, gene and phototherapy. In this Review, we survey the field for recent developments and strategies used in the smart design of nanocarriers for mitochondria-targeted therapeutics. Existing challenges and unexplored therapeutic opportunities are also highlighted and discussed to inspire the next generation of mitochondrial-targeting nanotherapeutics.
机译:线粒体是细胞的动力。它们是维持细胞功能和新陈代谢的重要细胞器。线粒体功能障碍导致多种疾病,临床表现多样。过去,人们已经开发了一些策略来制造亚细胞靶向给药纳米载体,从而实现细胞内化和随后的细胞器定位。最近,多功能纳米载体的智能设计出现了创新策略。分级靶向使纳米载体能够避开和克服体内给药时遇到的各种障碍,以达到具有良好生物利用度的细胞器。刺激响应性纳米载体允许治疗药物在所需靶点进行控制释放。协同治疗可以通过化疗、基因治疗和光疗等方法的结合来实现。在这篇综述中,我们综述了线粒体靶向治疗纳米载体智能设计的最新进展和策略。还强调和讨论了现有挑战和未探索的治疗机会,以启发下一代线粒体靶向纳米疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号